Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Poli

Showing results (161-170 of 186) with videos related to

Pageof 19
Sort By:
Drug Design, Development and Therapy|October 21, 2022
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort StudyVincenzo Spagnuolo, Marta Voarino, Marco Tonelli, et al.
Pediatric Blood & Cancer|August 12, 2020
Age-appropriate multidisciplinary approach to young children with cancer undergoing radiotherapy: The SIESTA procedureCarlo Alfredo Clerici, Andrea Ferrari, Emilia Pecori, et al.
Infectious Diseases (London, England)|January 25, 2023
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultationValentina Da Prat, Laura Galli, Paola Cichero, et al.
AIDS (London, England)|March 15, 2019
Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapyAntonella Castagna, Stefano Rusconi, Roberto Gulminetti, et al.
Toxins|July 28, 2019
A Probable Fatal Case of Oleander (Nerium oleander) Poisoning on a Cattle Farm: A New Method of Detection and Quantification of the Oleandrin Toxin in RumenSilva Rubini, Sabina Strano Rossi, Serena Mestria, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 23, 2020
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factorsMarco Ripa, Laura Galli, Andrea Poli, et al.
Open Forum Infectious Diseases|November 26, 2020
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO RegistryLaura Galli, Maria Rita Parisi, Andrea Poli, et al.
The Lancet. Rheumatology|March 3, 2021
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort studyGiulio Cavalli, Alessandro Larcher, Alessandro Tomelleri, et al.
Atherosclerosis. Supplements|August 28, 2019
The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinionMaciej Banach, Eric Bruckert, Olivier S Descamps, et al.
Antiviral Therapy|September 17, 2013
Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational settingAntonella d'Arminio Monforte, Nicola Gianotti, Alessandro Cozzi-Lepri, et al.
Pageof 19

Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
Drug Design, Development and Therapy|October 21, 2022
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort StudyVincenzo Spagnuolo, Marta Voarino, Marco Tonelli, et al.
Pediatric Blood & Cancer|August 12, 2020
Age-appropriate multidisciplinary approach to young children with cancer undergoing radiotherapy: The SIESTA procedureCarlo Alfredo Clerici, Andrea Ferrari, Emilia Pecori, et al.
Infectious Diseases (London, England)|January 25, 2023
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultationValentina Da Prat, Laura Galli, Paola Cichero, et al.
AIDS (London, England)|March 15, 2019
Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapyAntonella Castagna, Stefano Rusconi, Roberto Gulminetti, et al.
Toxins|July 28, 2019
A Probable Fatal Case of Oleander (Nerium oleander) Poisoning on a Cattle Farm: A New Method of Detection and Quantification of the Oleandrin Toxin in RumenSilva Rubini, Sabina Strano Rossi, Serena Mestria, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 23, 2020
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factorsMarco Ripa, Laura Galli, Andrea Poli, et al.
Open Forum Infectious Diseases|November 26, 2020
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO RegistryLaura Galli, Maria Rita Parisi, Andrea Poli, et al.
The Lancet. Rheumatology|March 3, 2021
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort studyGiulio Cavalli, Alessandro Larcher, Alessandro Tomelleri, et al.
Atherosclerosis. Supplements|August 28, 2019
The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinionMaciej Banach, Eric Bruckert, Olivier S Descamps, et al.
Antiviral Therapy|September 17, 2013
Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational settingAntonella d'Arminio Monforte, Nicola Gianotti, Alessandro Cozzi-Lepri, et al.
Pageof 19